CNBX PHARMACEUTICALS INC. Proceeds from Short-term Debt
CNBX PHARMACEUTICALS INC. (CNBX) reported Proceeds from Short-term Debt of $120.00 thousand for the 9-month period ending 2026-05-31, per its 10-Q filed 2026-06-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromShortTermDebt · last filed 2026-06-24
- CNBX PHARMACEUTICALS INC. proceeds from short-term debt for the quarter ending 2026-05-31 was $45.00K.
- CNBX PHARMACEUTICALS INC. proceeds from short-term debt for the quarter ending 2026-02-28 was $35.00K, a 68.18% decline year-over-year.
- CNBX PHARMACEUTICALS INC. proceeds from short-term debt for the quarter ending 2025-11-30 was $40.00K.
- CNBX PHARMACEUTICALS INC. proceeds from short-term debt for the quarter ending 2025-05-31 was -$110.00K.
| Period end | Proceeds from Short-term Debt 3 month | Proceeds from Short-term Debt 6 month | Proceeds from Short-term Debt 9 month |
|---|---|---|---|
| 2026-05-31 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-24 | $80.00K derived: sum of 2 quarters · filed 2026-06-24 | $120.00K 10-Q · filed 2026-06-24 |
| 2026-02-28 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-04-14 | $75.00K 10-Q · filed 2026-04-14 | |
| 2025-11-30 | $40.00K 10-Q · filed 2026-01-14 | ||
| 2025-05-31 | -$110.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-24 | $0.00 derived: sum of 2 quarters · filed 2026-06-24 | $0.00 10-Q · filed 2026-06-24 |
| 2025-02-28 | $110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-04-14 | $110.00K 10-Q · filed 2026-04-14 | |
| 2024-11-30 | $0.00 10-Q · filed 2026-01-14 |